37 related articles for article (PubMed ID: 38456653)
1. Recursive SVM biomarker selection for early detection of breast cancer in peripheral blood.
Zhang F; Kaufman HL; Deng Y; Drabier R
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S4. PubMed ID: 23369435
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis identifies a key gene HLA_DPA1 in severe influenza-associated immune infiltration.
Chen L; Hua J; He X
BMC Genomics; 2024 Mar; 25(1):257. PubMed ID: 38454348
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a diagnostic model of endometriosis based on disulfidptosis-related genes.
Shi H; Zhou C; Zhao Y
J Obstet Gynaecol Res; 2024 Apr; ():. PubMed ID: 38644543
[TBL] [Abstract][Full Text] [Related]
4. Screening of genes characteristic of pancreatic cancer by LASSO regression combined with support vector machine and recursive feature elimination, and immune correlation analysis.
Zeng L; Chen Z
J Int Med Res; 2024 Mar; 52(3):3000605241233160. PubMed ID: 38456653
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer biomarker detection by two support vector strategies for recursive feature elimination.
Wang Y; Liu K; Ma Q; Tan Y; Du W; Lv Y; Tian Y; Wang H
Biomark Med; 2019 Feb; 13(2):105-121. PubMed ID: 30767554
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning.
Liu J; Liu L; Antwi PA; Luo Y; Liang F
Front Genet; 2022; 13():858466. PubMed ID: 35719392
[No Abstract] [Full Text] [Related]
7. Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning.
Ji Y; Lin Z; Li G; Tian X; Wu Y; Wan J; Liu T; Xu M
Front Genet; 2023; 14():1136783. PubMed ID: 37732314
[No Abstract] [Full Text] [Related]
8.
Wu J; Guo Y; Zuo ZF; Zhu ZW; Han L
World J Gastroenterol; 2023 May; 29(19):2961-2978. PubMed ID: 37274806
[TBL] [Abstract][Full Text] [Related]
9. Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells.
Zhong Y; Zhang W; Hong X; Zeng Z; Chen Y; Liao S; Cai W; Xu Y; Wang G; Liu D; Tang D; Dai Y
Front Immunol; 2022; 13():873787. PubMed ID: 35757721
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma.
Li K; Huo Q; Minami K; Tamari K; Ogawa K; Na S; Fishel ML; Li BY; Yokota H
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894284
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
Zhang X; Liu SS; Ma J; Qu W
Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
[TBL] [Abstract][Full Text] [Related]
12. Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma.
Huang W; Li J; Zhou S; Li Y; Yuan X
Front Endocrinol (Lausanne); 2022; 13():883548. PubMed ID: 35800432
[TBL] [Abstract][Full Text] [Related]
13. The Ion Channel-Related Gene Signatures Correlated With Diagnosis, Prognosis, and Individualized Treatment in Patients With Clear Cell Renal Cell Carcinoma.
Zhu Z; Lei Z; Qian J; Zhang C; Gong Y; Yin G; Li Y; Li X; Lin J; Zhou L
Front Pharmacol; 2022; 13():889142. PubMed ID: 35721115
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
